# clm_F743D4B5E033

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 30,133,000,000 United States dollar  
valid_from: 2016-06-30  
valid_to: 2016-09-30  
published: 2016-07-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_99201951EE61  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 30,133,000,000 United States dollar", as of 2016-06-30 (until 2016-09-30). Claim clm_F743D4B5E033, https://asof.is/claim/clm_F743D4B5E033, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815416000046/0000318154-16-000046-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-07-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815416000046/0000318154-16-000046-index.htm (primary, SEC EDGAR 10-Q Q2 FY2016, published 2016-07-29)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 28,682,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_F743D4B5E033](/claim/clm_F743D4B5E033.md) | [clm_F89E040E0B16](/claim/clm_F89E040E0B16.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.